Redefining the viral reservoirs that prevent HIV-1 eradication
E Eisele, RF Siliciano - Immunity, 2012 - cell.com
This Perspective proposes definitions for key terms in the field of HIV-1 latency and
eradication. In the context of eradication, a reservoir is a cell type that allows persistence of …
eradication. In the context of eradication, a reservoir is a cell type that allows persistence of …
Life expectancy living with HIV: recent estimates and future implications
F Nakagawa, M May, A Phillips - Current opinion in infectious …, 2013 - journals.lww.com
Life expectancy living with HIV: recent estimates and future... : Current Opinion in Infectious
Diseases Life expectancy living with HIV: recent estimates and future implications : Current …
Diseases Life expectancy living with HIV: recent estimates and future implications : Current …
Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection
C Orkin, K Arasteh… - … England Journal of …, 2020 - Mass Medical Soc
Background Long-acting injectable regimens may simplify therapy for patients with human
immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3 …
immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3 …
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority …
DA Margolis, J Gonzalez-Garcia, HJ Stellbrink, JJ Eron… - The Lancet, 2017 - thelancet.com
Background Cabotegravir and rilpivirine are antiretroviral drugs in development as long-
acting injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
acting injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
[HTML][HTML] Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents
This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
[HTML][HTML] Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
Antiretroviral Therapy Cohort Collaboration - The Lancet, 2008 - Elsevier
BACKGROUND: Combination antiretroviral therapy has led to significant increases in
survival and quality of life, but at a population-level the effect on life expectancy is not well …
survival and quality of life, but at a population-level the effect on life expectancy is not well …
[图书][B] Scrambling for Africa: AIDS, expertise, and the rise of American global health science
JT Crane - 2013 - books.google.com
Countries in sub-Saharan Africa were once dismissed by Western experts as being too poor
and chaotic to benefit from the antiretroviral drugs that transformed the AIDS epidemic in the …
and chaotic to benefit from the antiretroviral drugs that transformed the AIDS epidemic in the …
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based …
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood… - The Lancet, 2010 - thelancet.com
Background Results of cohort studies and mathematical models have suggested that
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
Projected life expectancy of people with HIV according to timing of diagnosis
F Nakagawa, RK Lodwick, CJ Smith, R Smith… - Aids, 2012 - journals.lww.com
Methods: A stochastic computer simulation model of HIV infection and the effect of ART was
used to estimate life expectancy and determine the distribution of potential lifetime outcomes …
used to estimate life expectancy and determine the distribution of potential lifetime outcomes …
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
S Broder - Antiviral research, 2010 - Elsevier
In the last 25 years, HIV-1, the retrovirus responsible for the acquired immunodeficiency
syndrome (AIDS), has gone from being an “inherently untreatable” infectious agent to one …
syndrome (AIDS), has gone from being an “inherently untreatable” infectious agent to one …